Clinical Trial Update: Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sublingual immunotherapy for birch pollen-related apple allergy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apple Allergy
• Birch Pollen Allergy

Snippet

Sponsor: Medical University of Vienna | Conditions: Birch Pollen Related Apple Allergy, Birch Pollen Allergy | Phase 2 | Status: COMPLETED